2014•Journal of the American Society of HypertensionRequires access
Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings
Murray Esler
Open publisher page 126 citations
Abstract
This record does not include an abstract. Use the full-text link above if available.